Developing translational animal models for symptoms of schizophrenia or bipolar mania

Neurotoxicity Research

Volumn 14, Issue 1, 2008, Pages 71-78

  Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bipolar mania; Prepulse inhibition; Schizophrenia; Translational biomarkers

Indexed keywords

ARTICLE; BIPOLAR MANIA; COGNITIVE DEFECT; DISEASE MODEL; EVENT RELATED POTENTIAL; INFORMATION PROCESSING; MENTAL DISEASE; NEUROBIOLOGY; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; RODENT; SCHIZOPHRENIA; STARTLE REFLEX; SYMPTOM; VALIDATION PROCESS; ANIMAL; BIPOLAR DISORDER; HUMAN; REVIEW;

ANIMALIA; RODENTIA;

ANIMALS; BIPOLAR DISORDER; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; SCHIZOPHRENIA;

EID: 58149393059     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033576     Document Type: Article

References (44)

1. Braff DL and MA Geyer (1990) Sensorimotor gating and schizophrenia: human and animal model studies. Arch. Gen. Psychiatry 47, 181-188.
2. Braff DL, MA Geyer and NR Swerdlow (2001) Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156, 234-258.
3. Callaway CW, LL Wing and MA Geyer (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats. J. Pharmacol. Exp. Ther. 254, 456-464.
4. Cilia J, PD Hatcher, C Reavill and DNC Jones (2005) Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats: An update. Psychopharmacology 180, 57-62.
5. Cryan JF and DA Slattery (2007) Animal models of mood disorders: Recent developments. Curr. Opin. Psychiatry 20, 1-7.
6. Csomor PA, RR Stadler, J Feldon, BK Yee, MA Geyer and FX Vollenweider (2008) Haloperidol differentially modulates prepulse inhibition and P50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33, 497-512.
7. Drai D and I Golani (2001) SEE: A tool for the visualization and analysis of rodent exploratory behavior. Neurosci. Biobehav. Rev. 25, 409-426.
8. Eilam D, R Zor, H Szechtman and H Hermesh (2006) Rituals, stereotypy and compulsive behavior in animals and humans. Neurosci. Biobehav. Rev. 30, 456-471.
9. Einat H (2006) Modelling facets of mania - new directions related to the notion of endophenotypes. J. Psychopharmacology (Oxford, England) 20, 714-722.
10. Feifel D, G Melendez, K Priebe, PD Shilling (2007) The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats. Behav. Brain Res. 181, 278-86.
11. Fenton WS, EL Stover and TR Insel (2003) Breaking the logjam in treatment development for cognition in schizophrenia. Psychopharmacology 169, 365-366.
12. Floresco S, MA Geyer, LH Gold and A Grace (2005) Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophr. Bull. 31, 888-894.
13. Freedman R, LE Adler and S Leonard (1999) Alternative phenotypes for the complex genetics of schizophrenia. Biol. Psychiatry 45, 551-558.
14. Geyer MA (2006) Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia? Dialogues Clin. Neurosci. 8, 9-16.
15. Geyer MA and BA Ellenbroek (2003) Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 1071-1079.
16. Geyer MA and M Paulus (1996) Multivariate analyses of locomotor and investigatory behavior in rodents, In: Measuring Movement and Locomotion: From Invertebrates to Humans (Ossenkopp K, M Kavaliers & PR Sanberg, Eds.) (Chapman & Hall:NEw York, NY).
17. Geyer MA, PV Russo and VL Masten (1986) Multivariate assessment of locomotor behavior: Pharmacological and behavioral analyses. Pharmacol. Biochem. Behav. 25, 277-288.
18. Geyer MA, K Krebs-Thomson, DL Braff and NR Swerdlow (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology 156, 117-154.
19. Geyer MA, KL McIlwain and R Paylor (2002) Mouse genetic models for prepulse inhibition: An early review. Mol. Psychiatry 7, 1039-1053.
20. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153, 321-330.
21. Green MF, SR Kerns and RK Heaton (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophr. Res. 72, 45-51.
22. Hagan JJ and DN Jones (2005) Predicting drug efficacy for cognitive deficits in schizophrenia. Schizophr. Bull. 31, 830-853.
23. Kincaid MJ, A Minassian, EJ Ferguson, MA Geyer, MP Paulus and W Perry (2007) Exploratory behavior differentiates patients with acute psychotic mania from schizophrenia. Biol. Psychiatry 61, 139S.
24. Kumari V, W Soni and T Sharma (1999) Normalization of information processing deficits in schizophrenia with clozapine. Am. J. Psychiatry 156, 1046-1051.
25. Ludewig K, MA Geyer and FX Vollenweider (2003) Deficits in prepulse inhibition and habituation in never-medicated firstepisode schizophrenia. Biol. Psychiatry 54, 121-128.
26. Marder SR and W Fenton (2004) Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr. Res. 72, 5-9.
27. Martin LF, WR Kem and R Freedman (2004) Alpha-7 nicotinic receptor agonists: Potential new candidates for the treatment of schizophrenia. Psychopharmacology 174, 54-64.
28. Meltzer HY and SR McGurk (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull. 25, 233-255.
29. Minassian A, MA Geyer, MP Paulus, EJ Ferguson, R Sharp and W Perry (2007) Quantification of motor hyperactivity in mania: The human behavioral pattern monitor Biol. Psychiatry 61, 222S.
30. Nuechterlein KH, DM Barch, JM Gold, TE Goldberg, MF Green and RK Heaton (2004) Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 72, 29-39.
31. Olivier B, C Leahy, T Mullen, R Paylor, FE Groppi, Z Sarnyai and D Brunner (2001) The DBA/2J strain and prepulse inhibition of startle: A model system to test antipsychotics? Psychopharmacology 156, 284-290.
32. Ouagazzal A-M, F Jenck and J-L Moreau (2001) Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: A model for detecting antipsychotic activity. Psychopharmacology 156, 273-283.
33. Palmer AA, SC Dulawa, AA Mottiwala, LH Conti, MA Geyer and MP Printz (2000) Prepulse startle deficit in the Brown-Norway rat. A potential genetic model. Behav. Neurosci. 114, 374-388.
34. Paulus MP, A Minassian, V Masten, D Feifel, MA Geyer and W Perry (2007) Human behavioral pattern monitor differentiates activity patterns of bipolar manic and attention deficit hyperactivity subjects. Biol. Psychiatry 61, 227S.
35. Perry W, A Minassian, D Feifel and DL Braff (2001) Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol. Psychiatry 50, 418-424.
36. Powell SB and MA Geyer (2002) Developmental markers of psychiatric disorders as identified by sensorimotor gating. Neurotox. Res. 4, 489-502.
37. Risbrough VB, VL Masten, S Caldwell, MP Paulus, MJ Low and MA Geyer (2006) Differential contributions of dopamine D(1), D(2), and D(3) receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology 31, 2349-2358.
38. Swerdlow NR and MA Geyer (1993) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol. Biochem. Behav. 44, 741-744.
39. Swerdlow NR, MA Geyer and DL Braff (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: Current knowledge and future challenges. Psychopharmacology 156, 194-215.
40. Swerdlow NR, J Talledo, AN Sutherland, D Nagy and JM Shoemaker (2006) Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats. Neuropsychopharmacology 31, 2011-2021.
41. Vollenweider FX, M Barro, PA Csomor and J Feldon (2006) Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels. Biol. Psychiatry 60, 597-603.
42. Young, J, MA Geyer, and the TURNS Preclinical Subcommittee (2006) Cognitive task list and preclinical task survey. http://www.turns.ucla.edu/preclinical-TURNS-report-2006b.pdf
43. Young JW, A Minassian, MP Paulus, MA Geyer and W Perry (2007a) A reverse-translational approach to bipolar disorder: Rodent and human studies in the behavioral pattern monitor. Neurosci. Biobehav. Rev. 31, 882-896.
44. Young JW, AKL Goey, VL Masten, R Sharp, MP Paulus, W Perry and MA Geyer (2007b) Genetic and acute pharmacological animal models of bipolar disorder mania: Mimicking recent insights of disordered movement and exploration. Biol. Psychiatry 61, 38S.